Impact on long-term mortality of access and non-access site bleeding after primary percutaneous coronary intervention

ObjectivesThe influence of the bleeding site on long-term survival after the primary percutaneous coronary intervention (PCI) is poorly understood. This study sought to investigate the relationship between in-hospital access site versus non-access site bleeding and very late mortality in unselected...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Heart (British Cardiac Society) 2019-10, Vol.105 (20), p.1568-1574
Hauptverfasser: Matic, Dragan M, Asanin, Milika R, Vukcevic, Vladan D, Mehmedbegovic, Zlatko H, Marinkovic, Jelena M, Kocev, Nikola I, Marjanovic, Marija M, Mrdovic, Igor B, Antonijevic, Nebojsa M, Milosevic, Aleksandra D, Zivkovic, Milorad N, Krljanac, Gordana V, Stankovic, Sanja Dj, Milasinovic, Dejan G, Lasica, Ratko M, Stankovic, Goran R
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:ObjectivesThe influence of the bleeding site on long-term survival after the primary percutaneous coronary intervention (PCI) is poorly understood. This study sought to investigate the relationship between in-hospital access site versus non-access site bleeding and very late mortality in unselected patients treated with primary PCI.MethodsData of the 2715 consecutive patients with ST-segment elevation myocardial infarction treated with primary PCI, enrolled in a prospective registry of a high volume tertiary centre, were analysed. Bleeding events were assessed according to the Bleeding Academic Research Consortium (BARC) criteria. The primary outcome was 4-year mortality.ResultsThe BARC type ≥2 bleeding occurred in 171 patients (6.3%). Access site bleeding occurred in 3.8%, and non-access site bleeding in 2.5% of patients. Four-year mortality was significantly higher for patients with bleeding (BARC type ≥2) than in patients without bleeding (BARC type 0+1), (36.3% vs 16.2%, p
ISSN:1355-6037
1468-201X
DOI:10.1136/heartjnl-2019-314728